Vaxcyte Inc (PCVX) Stock Analysis

Vaxcyte Inc (PCVX) is a publicly traded company in the HEALTHCARE sector. It trades at $48.91, carries a market capitalization of $7.06B. This page summarizes the public market data, fundamentals, and frequently asked questions for PCVX, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $48.91
• Market Cap: $7.06B
• EPS: $-6.89
• 52-Week High: $65.00
• 52-Week Low: $29.08

Market Sentiment

Vaxcyte Inc currently has a Bullish sentiment score of 0.27.

About Vaxcyte Inc

Vaxcyte, Inc. (PCVX) is a cutting-edge biotechnology firm based in Foster City, California, dedicated to pioneering next-generation vaccines to address global infectious diseases. Utilizing its proprietary technology platform, Vaxcyte is developing innovative vaccine candidates that aim to deliver strong immunity and fulfill critical unmet medical needs. With a robust pipeline driven by a strong emphasis on research and development, the company is strategically positioned to significantly adv...

GNG Research Analysis

GNG Research scores Vaxcyte Inc (PCVX) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for PCVX.

Frequently Asked Questions

Does PCVX pay dividends?

Vaxcyte Inc (PCVX) does not currently pay a regular dividend.

What is PCVX's market cap?

Vaxcyte Inc (PCVX) has a market capitalization of $7.06B with a current stock price of $48.91.